From an investment perspective, Propanc offers a striking contrast to the high-valuation tech stocks now under rotation pressure. With a market capitalization under $15 million, it trades at a ...
Presentations showcase the power of omnimodal profiling to identify predictive immune signatures, comprehensively profile the tumor microenvironment and reveal novel therapeutic targets for optimized ...
FDA has taken steps to embrace AI in 2025, announcing in December that it will be providing agency staff with agentic AI ...
As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel methodologies, strategic innovation, and patient-centered approaches, MEDSIR is driving ...
Leading private healthcare provider, HCA Healthcare UK (HCA UK), is now live with MEDITECH Expanse across its 11 acute facilities and dozens of outpatient locations, enhancing patient safety and ...
A total of 38 companies were delisted from the Kosdaq market this year — 2.5 times more than the average of the past three ...
Patent protects ready to use liquid formulation of GerlinC which improves efficiency and focus for surgeons, resulting in a 10-minute procedureRobust IP portfolio includes 35 issued patents to date ...
Patent protects ready to use liquid formulation of GerlinC which improves efficiency and focus for surgeons, resulting in a 10-minute procedureRobust IP portfolio includes 35 issued patents to date wo ...
A dedicated bioimaging function at GSK has shown how integrated microscopy and analytics can deliver quantitative evidence ...
The theory behind antibody drug conjugates (ADCs) is simple yet elegant: by combining the specificity of a monoclonal antibody with the cytotoxicity of a potent small molecule drug, ADCs can precisely ...
A research team at Duke University has developed a new AI framework that can uncover simple, understandable rules that govern ...
Adding another potential wrinkle to the industry’s work with China is the Biosecure Act, a piece of China-targeting national ...